Curriculum Vitaes
Profile Information
- Affiliation
- Associate Professor, Department of Development and Education of Clinical Research, Fujita Health University School of Medicine(Concurrent)Committee Member, Office of Medical Education(Concurrent)Associate Professor, Preparatory Office for Clinical Research Core HospitalDepartment of Psychiatry, Department of Psychiatry, Jikei University
- Degree
- M.D.(Mar, 2010, Fujita Health University)Ph.D.(Mar, 2016, Fujita Health University)MPH(Mar, 2024, Kyoto University)
- researchmap Member ID
- B000247656
- External link
Research Interests
3Research Areas
1Research History
13-
Nov, 2025 - Present
-
Sep, 2024 - Present
Education
3-
Apr, 2023 - Mar, 2024
-
Apr, 2012 - Mar, 2016
-
Apr, 2004 - Mar, 2010
Committee Memberships
13-
Aug, 2025 - Present
-
Jul, 2025 - Present
-
Jan, 2025 - Present
-
Apr, 2024 - Present
-
Dec, 2023 - Present
-
Dec, 2021 - Present
-
Jul, 2021 - Present
-
2019 - Present
-
Sep, 2021 - Aug, 2023
Awards
9Papers
86-
Psychiatry and Clinical Neurosciences Reports, Aug, 2026 Peer-reviewedLead authorCorresponding author
-
Alpha Psychiatry, Aug, 2026 Peer-reviewedLead authorCorresponding author
-
Psychiatry and clinical neurosciences, Jun, 2026 Peer-reviewedLead authorCorresponding authorThis article relates to Model choice in meta-analysis should not be driven by Cochran's Q test.
-
Psychiatry and clinical neurosciences, May, 2026 Peer-reviewedLead authorCorresponding authorThis article relates to Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia.
-
Psychiatry and clinical neurosciences, Mar 10, 2026 Peer-reviewedAIM: We aimed to examine the psychometric properties of the second version of the Brief Evaluation of Psychosis Symptom Domains (BE-PSD-V2.0) and its correspondence with the Positive and Negative Syndrome Scale (PANSS) and Clinical Global Impression-Severity scale (CGI-S) scores. METHODS: This cross-sectional study was conducted at 18 institutes in Japan. We performed correlational analyses to test the convergent and divergent validity of the BE-PSD-V2.0. Inter-rater reliability was assessed using intraclass correlation coefficients (ICCs). The equipercentile equating method was employed to examine the linking of the BE-PSD-V2.0 with the PANSS and the CGI-S. RESULTS: A total of 353 patients with schizophrenia spectrum disorders were included. Spearman's rank correlation coefficients between the BE-PSD-V2.0 item scores and their corresponding PANSS factor scores ranged from 0.64 to 0.86, indicating sufficient convergent validity. These specific correlation coefficients were consistently the highest among all item-to-factor comparisons, indicating sufficient divergent validity. In 34 patients, ICCs for the BE-PSD-V2.0 item and total scores ranged from 0.60 to 0.94, showing sufficient inter-rater reliability. Conversion tables were established between the BE-PSD-V2.0 total score and the PANSS total score, between the BE-PSD-V2.0 total score and the CGI-S score, and between the BE-PSD-V2.0 item scores and their corresponding PANSS factor scores. A correspondence between symptomatic remission criteria using the PANSS and BE-PSD-V2.0 was confirmed. CONCLUSIONS: The BE-PSD-V2.0 possesses sufficient psychometric properties and corresponds to the PANSS and CGI-S. It is a sound and reliable brief rating scale for assessing symptoms in schizophrenia spectrum disorders, and its established conversion correspondences facilitate score interpretation within existing clinical paradigms for both clinical practice and research.
Major Misc.
112-
Japanese journal of clinical psychiatry, 55(11), Nov, 2026
-
Japanese journal of clinical psychopharmacology, 29(8) 867-874, Aug, 2026
-
Japanese Journal of Geriatric Psychiatry, 37(3) 236-241, Mar, 2026
-
Japanese journal of clinical psychopharmacology, 29(2) 197-204, Feb, 2026
-
Journal of Japanese Simulation Therapy Society, 6(1) 10-15, 2025 Peer-reviewed
-
Pain Clinic, 46(1) 95-100, Jan, 2025
-
Psychiatria et neurologia Japonica, 126(9) 589-598, Sep, 2024 Peer-reviewed
-
Japanese Journal of Clinical Psychopharmacology, 27(7) 691-698, Jul, 2024
-
Psychiatry, 43(4) 425-430, Oct, 2023
-
Psychiatry Resident, 2(4) 249-252, 2021
-
Japanese Journal of Clinical Psychopharmacology, 24(9) 937-942, 2021
-
Nippon Rinsho, 78(10) 1725-1730, Oct, 2020
-
Japanese Journal of Geriatric Psychiatry, 29(12) 1266-1272, Dec, 2018
-
Japanese journal of clinical psychiatry, 47(8) 861-867, Aug, 2018
-
Clinical Psychiatry, 60(1) 91-97, Jan, 2018
-
Japanese Journal of Clinical Psychopharmacology, 20(12) 1441-1447, Dec, 2017
-
Functional Neurosurgery, 56 15-22, Dec, 2017
-
Japanese journal of psychiatric treatment, 32(10) 1339-1345, Oct, 2017
-
Psychiatry, 30(6) 524-529, Jun, 2017
-
Japanese journal of psychiatric treatment, 32(4) 525-531, Apr, 2017
-
Japanese Journal of Clinical Psychopharmacology, 19(12) 1717-1723, Dec, 2016
-
Japanese Journal of Clinical Psychopharmacology, 18(10) 1269-1276, Oct, 2015
-
Japanese Journal of Clinical Psychopharmacology, 18(6) 741-746, Jun, 2015
-
Progress in Medicine, 33(11) 2323-2328, Nov, 2013
Books and Other Publications
3-
IGAKU-SHOIN, Jul, 2023 (ISBN: 9784260053174)
-
IGAKU-SHOIN, Jun, 2022 (ISBN: 9784260049870)
-
IGAKU-SHOIN, Jun, 2016 (ISBN: 9784260024914)
Presentations
141Teaching Experience
9-
Apr, 2026 - PresentIntroduction to Clinical Research (Fujita Health University School of Medicine)
-
Apr, 2024 - PresentPreparatory Education for Clinical Clerkship (School of Medicine, Fujita Health University, Faculty of Medicine)
-
Apr, 2024 - PresentMedical Research Seminar (Fujita Health University School of Medicine)
-
Apr, 2024 - PresentCoordinator, Human Behavior and Psychology I (Fujita Health University School of Medicine)
-
Apr, 2022 - Mar, 2023Clinical Medicine III, Clerkship in Psychiatry (Course Director) (Jikei University School of Medicine)
Professional Memberships
9Research Projects
6-
Japan Agency for Medical Research and Development (AMED), Apr, 2025 - Mar, 2028
-
Disability Support Comprehensive Research Development Program, Japan Agency for Medical Research and Development (AMED), Apr, 2024 - Mar, 2025
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2022 - Mar, 2025
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2018 - Mar, 2024
-
Disability Support Comprehensive Research Development Program, Japan Agency for Medical Research and Development (AMED), Apr, 2022 - Mar, 2023
Academic Activities
9-
Planning/Implementing academic researchJapanese Society of Neuropsychopharmacology (JSNP), Japanese Socirty of Clinical Neuropsychopharmacology (JSCNP)
-
Planning/Implementing academic researchJapanese Society of Neuropsychopharmacology (JSNP), Japanese Socirty of Clinical Neuropsychopharmacology (JSCNP)
-
Planning/Implementing academic researchJapanese Society of Neurology
-
Planning/Implementing academic researchJapanese Society of Psychiatry and Neurology (JSPN)
-
Planning/Implementing academic research2019 MHLW Grant-in-Aid for Scientific Research, Comprehensive Research Project on Disability Policy
Major Social Activities
19Media Coverage
5-
TEIJIN, NeuroMyStar, Clinical Report / Seminar Report, Jul, 2025 Internet
-
Chunichi Shimbun, Medical Advice Column, Dec, 2023 Newspaper, magazine
-
TEIJIN, NeuroMyStar, Clinical Report / Seminar Report, May, 2023 Internet
-
TEIJIN, NeuroMyStar, Clinical Report / Seminar Report, Feb, 2022 Internet
-
TSUMURA, QLife Kampo, Special Feature: The Effectiveness of Kampo Medicine, The Efficacy of Yokukansan, Aug, 2013 Internet
Other
1-
May, 2026JAMA Psychiatry, JAMA Network, May 14, 2026 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2848043